HLA-E and B-cell chronic lymphocytic leukemia: Furthermore, alongside downregulation of HLA-E, selinexor can enhance death receptor surface expression on CLL cells, which can improve NK-mediated lysis via engagement with TNF-related apoptosis-inducing ligand (TRAIL) [62].